This federal Project Grant award in the amount of $582,189.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Virginia Commonwealth University (VCU) to investigate the role of histone H2A ubiquitination and the RSF1 gene in breast cancer. The 3-year award, starting on March 1, 2024, will fund personnel, facilities, and equipment to conduct basic, translational, and clinical research aimed at advancing...
This $1,836,611 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research at Virginia Commonwealth University (VCU) to develop a novel cell therapy for the treatment of advanced prostate cancer. The award, effective September 1, 2025 through August 31, 2028, will enable VCU researchers to explore innovative approaches to disease prevention, diagnosis, treatment, and management of...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,552,466.00 to Virginia Commonwealth University (VCU) to develop unique oncolytic adenoviruses for the pursuit of ovarian cancer cells. The award term is from May 1, 2025 through April 30, 2029. As a comprehensive research university, VCU will utilize the funding to advance innovative biomedical research focused on transforming healthcare...
Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $961,900.00 to Virginia Commonwealth University (VCU) for the Early Detection of Cancer Disparity and Treatment Resistance in TNBC project. The 3-year award, effective February 1, 2024, supports research to advance early detection and treatment of triple-negative breast cancer (TNBC), which disproportionately impacts minority populations. The funding will enable...
The Virginia Commonwealth University (VCU) was awarded a $768,002 Project Grant from the Office of the Secretary of Defense to support basic, applied, and advanced research in science and engineering fields from June 5, 2023 through June 4, 2027. The grant funds VCU research under the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630), which supports research with potential to contribute to Department of Defense technology. VCU researchers will conduct...
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
The Virginia Commonwealth University will receive $1.5 million over four years from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to manage distress in malignant brain cancer. Through this Project Grant award issued on August 1, 2021 and concluding on July 31, 2025, VCU will provide services to transform healthcare for service members and the public through innovative research investigating medical solutions for the...
The Defense Health Agency awarded a $3,995,791 project grant to Virginia Commonwealth University under the Military Medical Research and Development program (CFDA 12.420) to compare the attentional demands and functional outcomes of pattern recognition and direct myoelectric control in people with transradial amputation. VCU will conduct this research from September 2023 through September 2027 in Richmond, Virginia. Two subawards were also provided. Hanger Institute for Clinical Research and...
The Virginia Commonwealth University (VCU) was awarded a $799,338 Project Grant from the Office of the Secretary of Defense to support basic, applied, and advanced research in science and engineering under the Basic, Applied, and Advanced Research in Science and Engineering federal grant program (CFDA 12.630). The four-year award beginning June 1, 2023 will fund VCU research personnel, facilities, and equipment to conduct studies and develop technologies with potential to contribute to...